InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Tilton John, Executive. Director active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 3 reports have been published. History available since 25 November 2021. The latest transaction was filed on 3 October 2022 (Disposition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
John Tilton is the Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd. He oversees the company's business strategies, which focus on developing innovative treatments. Biohaven is recognized for its commitment to innovation in the pharmaceutical sector. John's experience is crucial for the company's growth.